Rivernorth Capital Management’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.94M Buy
229,844
+67,161
+41% +$860K 0.16% 168
2025
Q1
$2.06M Buy
162,683
+122,869
+309% +$1.56M 0.11% 168
2024
Q4
$522K Buy
+39,814
New +$522K 0.03% 206